Thyrocare Technologies Limited reports revenue of INR 270.8 Cr in Q2 FY27, with a growth of 25.1% YoY
Thyrocare Reports Strong Q2FY27 Results – Revenue Up 25.1%, PAT before Exceptional Items Up 25.7% Navi Mumbai (Maharashtra) [India], October 29: Thyrocare Technologies Limited (hereinafter referred to as “Thyrocare” NSE: THYROCARE, BSE: 539871), a leading healthcare diagnostics company, today announced its results for the quarter ended September 30, 2026. The Company delivered a robust performance […]
Continue Reading